A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract
| Authors: | Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; Drullinsky, P.; Friedberg, J. W.; Hamlin, P. A.; Hoppe, R. T.; Matasar, M. J.; McArthur, G. N.; Miller, S. T.; Moskowitz, A. J.; Noy, A.; Schoder, H.; Straus, D. J.; Yang, J.; Younes, A.; Zelenetz, A. D.; Yahalom, J.; Moskowitz, C. H. |
| Abstract Title: | A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma |
| Meeting Title: | 14th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 14-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-06-07 |
| Start Page: | 171 |
| End Page: | 172 |
| Language: | English |
| ACCESSION: | 123459895 |
| DOI: | 10.1002/hon.2438_30 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 170 -- Accession Number: 123459895 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
Altmetric
Citation Impact
BMJ Impact Analytics
